---
title: "“Spectrum of ocular toxicities from epidermal growth factor receptor inhibitors and their intermediate-term follow-up: a five-year review”, Supportive Care in Cancer (2012)"
description: "Link to Publication: [https://link.springer.com/article/10.1007/s00520-012-1645-y](https://link.springer.com/article/10.1007/s00520-012-1645-y) Abstract: Epidermal growth factor receptor (EGFR) inhibitors and kinases are commonly used in the treatment regimen of various solid tumors including non-small cell lung, colorectal, head and neck, breast, and pancreatic cancers. The aim of this…"
url: "https://eyedrugtox.com/docs/spectrum-of-ocular-toxicities-from-epidermal-growth-factor-receptor-inhibitors-and-their-intermediate-term-follow-up-a-five-year-review-supportive-care-in-cancer-2012/"
updated: "2023-03-17"
category: EGFR Inhibitors
---

# “Spectrum of ocular toxicities from epidermal growth factor receptor inhibitors and their intermediate-term follow-up: a five-year review”, Supportive Care in Cancer (2012)

Link to Publication:

[https://link.springer.com/article/10.1007/s00520-012-1645-y](https://link.springer.com/article/10.1007/s00520-012-1645-y)

Abstract: Epidermal growth factor receptor (EGFR) inhibitors and kinases are commonly used in the treatment regimen of various solid tumors including non-small cell lung, colorectal, head and neck, breast, and pancreatic cancers. The aim of this study is to describe common ocular adverse effects associated with EGFR inhibitor treatment, outline successful management options, and provide data on intermediate-term follow-up of these patients.